Skip NavigationSkip to Content
Return Return to Search Results

Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival

  1. Author:
    Bian, X. W.
    Yang, S. X.
    Chen, L. H.
    Ping, Y. F.
    Zhou, X. D.
    Wang, Q. L.
    Jiang, X. F.
    Gong, W. H.
    Xiao, H. L.
    Du, L. L.
    Chen, Z. Q.
    Zhao, W.
    Shi, L. Q.
    Wang, J. M.

  2. Author Address

    Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China. Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing 400038, Peoples R China. SAIC Frederick Inc, Basic Res Program, Frederick, MD USA. NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, NIH, Frederick, MD 21702 USA.;Bian, XW, Third Mil Med Univ, Southwest Hosp, Inst Pathol, Gaotanyan 30, Chongqing 400038, Peoples R China.;bianxiuwu@263.net
    1. Year: 2007
    2. Date: Sep
  2. Journal: Neurosurgery
    1. 61
    2. 3
    3. Pages: 570-578
  4. Type of Article: Article
  5. ISSN: 0148-396X
  1. Abstract:

    OBJECTIVE: CXCR4 is implicated in the growth, metastasis, and angiogenesis of malignant tumors. We investigated the potential role of CXCR4 in human gliomas. METHODS: The expression of CXCR4 messenger ribonucleic acid and protein by human glioma cell lines was examined by reverse-transcriptase polymerase chain reaction and immunocytochemistry analysis. Tumor cell chemotaxis and production of vascular endothelial growth factor induced by the CXCR4 ligand SDF-1 beta were measured. Xenograft models were used for evaluation of glioma cell tumorigenesis. CXCR4 expression by xenografted tumors and primary human glioma specimens were evaluated for CXCR4 protein expression. The relationship between CXCR4 expression and patient survival was analyzed. A synthetic lipoxygenase inhibitor, Nordy, was tested for its effects on glioma cell expression and function of CXCR4, as well as on glioma cell tumorigenicity. RESULTS: CXCR4 expression correlated directly with the degree of malignancy of the human glioma cell lines and primary tumors. Activation of CXCR4 induced tumor cell chemotaxis and increased production of vascular endothelial growth factor. Glioma cells expressing higher levels of CXCR4 formed more rapidly growing and lethal tumors in nude mice. Primary human glioma specimens expressing CXCR4 contained high-density microvessels. Patients with CXCR4-positive gliomas had poorer prognosis after surgery. The lipoxygenase inhibitor Nordy diminished CXCR4 expression by glioma cell lines in vitro and reduced their tumorigenicity in nude mice. CONCLUSION: The level of CXCR4 expression seems to correlate with the degree of malignancy of human gliomas and may contribute to their rapid growth.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1227/01.neu.0000255478.83376.ef
  3. View record in Web of Science®
  4. WOS: 000249720600044

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel